Presentations from the 4th Annual Viral Safety and Viral Clearance Summit

October 8 – 9, 2019 | San Francisco, CA

4th Annual Viral Safety and Viral Clearance Summit 2019 logo

Thank you for attending the 4th Annual Viral Safety and Viral Clearance Summit. Please use the links below to download the PDFs of the presentations.
 

Tuesday, October 8, 2019

Viral Safety Strategies for Biologicals: How to Think About Risk | Eleonora Widmer, MD, PhD
Viral Safety for Advanced Therapies: Blood Products and Cell/Gene Therapies | Dorothy Scott, MD 
Current Trends in Viral Clearance and Safety | Kurt Brorson, PhD
Mitigate the Risk of Viral Contamination of the Bioreactor: Implementation of the Viresolve® Barrier Virus Filter for Chemically Defined Cell Culture Media | Corinne Miller, PhD
Optimizing Membrane Adsorbers for Robust Parvo Virus (MVM) Clearance | Sherri Dolan
From "Batch Mode" To "Continuous" Bioprocessing: How The Virus Filter Fits In | Brian Buesing 

 

Wednesday, October 9, 2019

Viral Safety and Viral Clearance for Cell and Gene Therapy Products: Trends and Regulatory Considerations | Zenobia Taraporewala, PhD
Adventitious Agent Mitigation Strategies in the Manufacturing of Viral Gene Transfer Vectors | Hetal Brahmbhatt, PhD
Foundations of Viral Safety for Allogeneic Cell Therapies | Houman Dehghani, PhD
A Reference Virus Database (RVDB) to Facilitate High-Throughput Sequencing Bioinformatics Analysis for Detection of Known and Novel Adventitious Viruses | Pei-Ju Chin, PhD
Analysis of the Cell Transcriptome by Next Generation Sequencing of Newly Synthetized RNAs: Sensitive Detection of Cell Infection by Viruses and Mycoplasma and Differentiation from Inert Sequences | Marc Eloit, DVM, PhD
Viral Contamination in the Baculovirus-Insect Cell System | Donald L. Jarvis, PhD
A Response Plan to a Viral Contamination in a Bioproduction Facility | Yuval Shimoni, PhD